Upsher-Smith to Pay up to $555 Million for Proximagen

13.06.2012 - U.S. drugmaker Upsher-Smith Laboratories is to buy British group Proximagen for 223 million pounds ($347 million) plus further payments potentially worth up to 134 million based on...